ENTRY       D10791                      Drug
NAME        Nusinersen sodium (JAN);
            Spinraza (TN)
PRODUCT     SPINRAZA (Biogen)
FORMULA     C234H323N61O128P17S17.17Na
EXACT_MASS  7495.9693
MOL_WEIGHT  7500.8854
REMARK      Therapeutic category: 1190
            ATC code: M09AX07
            Chemical structure group: DG02002
            Product (DG02002): D10791<JP/US>
EFFICACY    Translation inhibitor
  DISEASE   Spinal muscular atrophy [DS:H00455]
  TYPE      Antisense oligonucleotide
COMMENT     Treatment of spinal muscular atrophy
TARGET      SMN2 [HSA:6607] [KO:K13129] (pre-mRNA intron7)
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
               M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
                M09AX Other drugs for disorders of the musculo-skeletal system
                 M09AX07 Nusinersen
                  D10791  Nusinersen sodium (JAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Nusinersen
               D10791  Nusinersen sodium (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               119  Miscellaneous
                1190  Miscellaneous
                 D10791  Nusinersen sodium (JAN)
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Signaling molecules
               Spliceosome
                SMN2
                 D10791  Nusinersen sodium (JAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10791
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10791
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10791
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10791
DBLINKS     PubChem: 315431340
///
